Thioxothiazolidine derivative having Ras function inhibitory effect

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9056862
APP PUB NO 20140194412A1
SERIAL NO

14116152

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides an anticancer drug having a Ras function inhibitory action.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITYKOBE-SHI HYOGO 657-8501
KNC LABORATORIES CO LTDKOBE HYOGO 650-0047

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kataoka, Tohru Kobe, JP 8 16
Neya, Masahiro Kobe, JP 26 273
Sasahara, Daisuke Kobe, JP 2 0
Shima, Fumi Kobe, JP 4 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 16, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00